News 併用療法で呼吸を楽に 2015年11月1日 Nature Biotechnology 33, 11 doi: 10.1038/nbt.3397 The first approved combination therapy against cystic fibrosis will open up an increasing proportion of patients for treatment. As Anna Azvolinsky reports, companies are banking on it. Full text PDF 目次へ戻る
